Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pascal Soriot

Top UK CEOs handed 16% pay rise as millions of workers squeezed – as it happened

Data from the High Pay Centre thinktank showed FTSE 100 bosses collected an average £500,000 pay rise last year, taking their median pay to £3.9m

The Guardian - UK

FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’

CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation

The Guardian - UK

Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca pledges to plant and maintain 200m trees globally by 2030

Drugmaker’s $4oom offsetting scheme aims to combat climate change and biodiversity loss caused by deforestation

The Guardian - UK

AstraZeneca China boss pledges to ‘love the Communist Party’

BEIJING: The global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said on Friday.

Bangkok Post

UK and Europe are falling behind US and China in biotech, says AstraZeneca boss

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China

The Guardian - UK

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

UK's richest fatcats get gigantic 40percent pay rise - SIX times the average salary

The Mirror analysed figures for all 60 FTSE 100 companies that have published annual reports this year. We looked at total packages for 120 bosses - of those, 54 earned more than last year and 49 made less

Daily Mirror

UK avoids recession, but growth is nowhere to be found

As any A-level economics teacher will tell you, the key to explaining the concept of falling inflation is that while prices are still rising, they are doing so at a slower rate.

Evening Standard

Take AstraZeneca’s warning seriously. The UK is missing out in life sciences

Big pharma has choices about where to make new investments and, increasingly it seems, it is not choosing Britain

The Guardian - UK

AstraZeneca buys US biotech firm CinCor

London (AFP) - Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.

AFP

Covid vaccine concerns were overblown, says AstraZeneca boss as he is knighted

Sir Pascal Soriot was speaking after he was knighted by the King at Windsor Castle on Wednesday.

The Independent UK

Actors Damian Lewis and William Roache set to receive royal honours

Lewis, star of the award-winning shows Homeland and Band Of Brothers and who started a fundraiser to feed NHS staff healthy meals, will be made a CBE

The Independent UK

AstraZeneca’s CEO on Covid: ‘We Just Have to Adjust to it’

AstraZeneca’s Chief Executive Officer, Sir Pascal Soriot, told Asharq Al-Awsat in an interview that Covid-19 is not over “and we just have to adjust to it like we live with the flu.” “Most people who get it basically get sick for a few days and do not need to be…

Asharq Al-Awsat

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

Wales Online

AstraZeneca boss uncertain if yearly Covid-19 boosters for healthy are good use of resources

The chief executive officer believes most of the vaccinated population now has a "foundation immunity against severe disease"

The Independent UK

AstraZeneca boss unsure if annual Covid-19 boosters are good use of resources

Chief executive officer Pascal Soriot said he believes most of the vaccinated population has a ‘foundation immunity against severe disease’.

The Independent UK

FTSE 100 chief executive average pay jumps by 39% to £3.4m

“To see CEO pay rocketing to more than 100 times the average salary is sickening,” say union bosses

Get all your
news in one place.

100’s of premium titles.
One news app.

Wales Online

AstraZeneca boss 'wouldn't change a thing' despite Covid vaccine 'setbacks'

Jab saved one million lives, says Sir Pascal Soriot

Bangkok Post

AstraZeneca’s Pascal Soriot awarded British knighthood

AstraZeneca’s Chief Executive Officer, Pascal Soriot, today received a British knighthood for services to UK life sciences and leadership in the global response to the COVID pandemic in the Queen’s Birthday Honours 2022.

Crikey

Aussie AstraZeneca CEO honoured by Queen

The Australian boss of pharmaceutical giant AstraZeneca, which produced a crucial vaccine against COVID-19, has been given a knighthood by the Queen.

Birmingham Post

Fragrance Shop and Iceland bosses among business leaders on Queen's Birthday Honours list for Platinum Jubilee

Liverpool events chief and East Lancashire Chamber CEO also honoured

The Guardian - UK

AstraZeneca boss calls for UK to provide new Covid-19 medicine to the vulnerable

Pharmaceutical CEO says it’s ‘sad’ that UK has failed to order Evusheld for the immunosuppressed

Evening Standard

AstraZeneca faces revenue hit as Covid-19 vaccine demand falls

Pharmaceutical giant has also announced plans to open a new research and development centre in Boston, Massachusetts

Benzinga

AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook

AstraZeneca Plc's (NASDAQ:AZN) total revenue jumped 60% Y/Y at CER to $11.39 billion in Q1 FY22, beating the consensus of $10.99 billion. The growth reflects the contribution of the Alexion medicines and several Vaxzevria contracts that are expected to complete the delivery by half year 2022. Core EPS came in at $1.89,…

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.